Adjusted for age and sex | Adjusted for age, sex, and CVD risk factorsa | Adjusted for age, sex, CVD risk factorsa, surgical interventionb, HTNmed.c | Adjusted for age, sex, CVD risk factors a, surgical interventionb, HTNmed.cand statin use | |||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Death from CVD | ||||||||
Reykjavik Study: with T2D vs. without T2D | 2.21 | 1.46-3.34 | 1.88 | 1.24-2.85 | 1.89 | 1.25-2.87 | 1.89 | 1.24-2.86 |
AGES-Reykjavik: with T2D vs. without T2D | 1.69 | 1.30-2.20 | 1.46 | 1.11-1.91 | 1.46 | 1.12-1.92 | 1.47 | 1.12-1.93 |
Death from all causes | ||||||||
Reykjavik Study: with T2D vs. without T2D | 1.66 | 1.23-2.25 | 1.55 | 1.14-2.11 | 1.56 | 1.15-2.11 | 1.54 | 1.13-2.09 |
AGES-Reykjavik: with T2D vs. without T2D | 1.47 | 1.23-1.75 | 1.38 | 1.15-1.65 | 1.38 | 1.15-1.65 | 1.39 | 1.16-1.67 |